$1,000 invested Gilead Sciences Inc. (2023)
NASDAQ · GILD · reinvest dividends · adjusted close
●Result2023-01-03 — 2026-10-15
Today you would have
$2,060
+$1,060 (+105.97%)
GILDSPY (benchmark)
- Entry price
- $76.40
- Current price
- $157.37
- Shares
- 13.0882
- CAGR
- +21.06%
- Max Drawdown
- -26.59%
- vs SPY
- -5.44 pp
✦The story
A $1,000 position in Gilead Sciences opened in early 2023 was worth $2,060 by mid-2026, a gain of +106.0%. The biotech continued to rely on its HIV treatment franchise while expanding into oncology. Over the same period the S&P 500 gained +111.4%, outpacing the stock.
#Related scenariosfor comparison
Other years for GILD